Active, Not Recruiting
Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole
NCT05286437
- Conditions
- Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
- Locations
-
- National Cancer Centre Singapore Singapore